Please enjoy these video excerpts from the Integrated Healthcare Training Series. The National Register created this series to help position Health Service Psychologists as essential team members in integrated healthcare. There are 42 videos available on the National Register's continuing education site,, which cover theory, models, and implementation as well as discussion of the medical, pharmacological, and psychosocial management of conditions that commonly present in integrated settings.

15-Minute Relationship with Bob McGrath, PhD

Dr. McGrath reinvisions the traditional psychologist-patient relationship to fit the integrated primary care environment and pace, and provide the patient with functional stability rather than a transformative experience.

Insomnia Biopsychosocial Assessment & Treatment with Jeffrey Goodie, PhD, ABPP

Dr. Goodie discusses assessment and psychological management of chronic insomnia. Assessment instruments and principles of psychological treatment in the integrated setting are covered.

Psychological Factors Related to Celiac Disease with Mi-Young Ryee, PhD

Dr. Ryee discusses the assessment and management of celiac disease and other gluten-related conditions.

Population Health with Parinda Khatri, PhD

Dr. Khatri describes the concepts of population care including measuring the health of the community instead of the individual, the triple aim, patient and family centered care, and value based payment models.

Substance Abuse Assessment and Management with Jeff Reiter, PhD, ABPP

Dr. Reiter discusses assessment and management of substance abuse issues, including assessment devices and intervention strategies for individuals and families in the primary care environment.

Diabetes Pharmacological Interventions with Morgan T. Sammons, PhD, ABPP

Dr. Sammons presents an overview of medications commonly used in the management of both Type I and Type II diabetes in the integrated care environment. Diagnosis, ADA treatment recommendations, and drug classes are discussed, including insulin, sulfonylureas, biguanides, and glucagon-like-peptide agonists.